Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) EBT Margin: 2011-2025

Historic EBT Margin for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -2,640.47%.

  • Abeona Therapeutics' EBT Margin rose 3215149.00% to -2,640.47% in Q3 2025 from the same period last year, while for Sep 2025 it was -4,976.54%, marking a year-over-year increase of 739651.00%. This contributed to the annual value of -180,050.00% for FY2024, which is 17869134.00% down from last year.
  • Per Abeona Therapeutics' latest filing, its EBT Margin stood at -2,640.47% for Q3 2025, which was up 12.20% from -3,007.25% recorded in Q2 2025.
  • Over the past 5 years, Abeona Therapeutics' EBT Margin peaked at 97,227.08% during Q4 2021, and registered a low of -34,791.95% during Q3 2024.
  • For the 3-year period, Abeona Therapeutics' EBT Margin averaged around -3,533.77%, with its median value being -2,640.47% (2025).
  • As far as peak fluctuations go, Abeona Therapeutics' EBT Margin surged by 9,775,468bps in 2021, and later tumbled by 11,651,238bps in 2022.
  • Abeona Therapeutics' EBT Margin (Quarterly) stood at 97,227.08% in 2021, then tumbled by 11,651,238bps to -19,285.29% in 2022, then surged by 1,718,466bps to -2,100.63% in 2023, then skyrocketed by 3,219,216bps to 30,091.53% in 2024, then surged by 3,215,149bps to -2,640.47% in 2025.
  • Its last three reported values are -2,640.47% in Q3 2025, -3,007.25% for Q2 2025, and -6,642.63% during Q1 2025.